Condition
Ovarian Serous Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Ovarian Serous Adenocarcinoma clinical trials that are recruiting, at sites in 5 countries (most in United States (2), Canada (1), Italy (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
Combining APL-2 with Pembrolizumab and Bevacizumab for Recurrent Ovarian Cancer
This study is testing if a new treatment combining APL-2 with pembrolizumab and bevacizumab can help people with recurrent ovarian cancer feel better and live longer compared to just using bevacizumab alone.
-
Minimally invasive surgery for advanced ovarian cancer after chemotherapy
This study is testing if a less invasive surgery is just as effective as traditional surgery for women with advanced ovarian cancer after they have had chemotherapy.
Related topics
Quick answers
How many Ovarian Serous Adenocarcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (2 trials), Canada (1 trial), Italy (1 trial), Mexico (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.